Laparoscopy Robot Articles & Analysis: Older
13 news found
On-demand robotics is a new technique for laparoscopic surgery. It has been used in Germany for the first time by the Department for Women’s Health and Gynecology at the University Hospital Tübingen. Together with the University Hospital Tübingen we announced today the successful completion of gynecological surgeries using Dexter®. This marks Dexter’s first clinical ...
Surgeons at Lausanne University Hospital (CHUV) perform the world’s first hybrid robotic general surgery. Distalmotion and CHUV announce the launch of a clinical study. ...
June 8.2022 - Medical Microinstruments (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced that it will participate in "THE MINIMALLY INVASIVE ROBOTIC SURGERY SYSTEMS project (TREMIRS). ...
BOSTON — May 24, 2022 — Activ Surgical™, a digital surgery pioneer, today announced the successful completion of an Institutional Review Board (IRB) study using its ActivSight™ intraoperative imaging module at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo (UB) in New York. The 40-patient study was led by principal investigator Dr. ...
(“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, announced today the sale of its in-office MRI system to Arizona Urology, a comprehensive urological care center with three physician offices in the surrounding Phoenix area. ...
Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, announced today the sale of its in-office MRI system to Beverly Hills Urology. Promaxo’s single-sided MRI with AI based imaging system, FDA cleared for in-office use, empowers practices and hospitals to accurately and seamlessly guide prostate interventions under the ...
As part of an exclusive regional distributor mandate NBA Medica will make Dexter®, the world’s first and only on-demand robotic surgery system, available to Italian healthcare providers. Dexter’s novel approach to robotic surgery integrates proven laparoscopic workflows into the robotic setup, always giving surgeons access to the ...
Distalmotion, Revival Healthcare Capital and 415 CAPITAL announce the closing of a USD 90 million Series E financing round to accelerate the adoption of Distalmotion’s surgical robot Dexter. The investment follows Dexter’s successful initial clinical use and supports Distalmotion’s international commercial scaling. More than capital: A partnership of medtech pioneers and ...
“We are honored to have Duncan, Chad, Stavit and Gus join our team as their broad industry experience including at prominent surgical and robotics companies will be instrumental as we expand commercial opportunities for Hominis. ...
Senhance goes beyond the typical surgical robotic systems, providing surgical assurance through haptic feedback, eye-tracking camera control, and 3D visualization, and is the first platform to offer 3 mm instruments (the smallest instrument available in the world on a robotic surgical platform). ...
The name change reflects the company's broader vision of shaping the future of surgery by integrating computer vision and machine learning with surgical robotics. Upcoming 2021 Milestones For the full year 2021, the Company expects to install 10 - 12 new Senhance Surgical Systems. During the first half of 2021, the Company expects to achieve the following regulatory ...
The new Cellvizio®platform includes significant improvements and will enable major innovations Mauna Kea Technologies announced today that it has obtained 510(k) clearance (K193416) from the U.S. Food and Drug Administration (FDA) and CE marking of the next-generation Cellvizio® endomicroscopy platform, built with the company’s new proprietary system architecture. This marks the ...
The Cellvizio®100 series system with all its different Confocal Miniprobes™ is now cleared for use with the fluorescein dye to image blood flow in the microvasculature and capillaries Mauna Kea Technologies today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Cellvizio® 100 series and all associated Confocal Miniprobes™ for ...